Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Thymosin Immune Modulators Market Size Analysis from 2022 to 2027

1.5.1 Global Thymosin Immune Modulators Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Thymosin Immune Modulators Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Thymosin Immune Modulators Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Thymosin Immune Modulators Industry Impact

Chapter 2 Global Thymosin Immune Modulators Competition by Types, Applications, and Top Regions and Countries

2.1 Global Thymosin Immune Modulators (Volume and Value) by Type

2.1.1 Global Thymosin Immune Modulators Consumption and Market Share by Type (2016-2021)

2.1.2 Global Thymosin Immune Modulators Revenue and Market Share by Type (2016-2021)

2.2 Global Thymosin Immune Modulators (Volume and Value) by Application

2.2.1 Global Thymosin Immune Modulators Consumption and Market Share by Application (2016-2021)

2.2.2 Global Thymosin Immune Modulators Revenue and Market Share by Application (2016-2021)

2.3 Global Thymosin Immune Modulators (Volume and Value) by Regions

2.3.1 Global Thymosin Immune Modulators Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Thymosin Immune Modulators Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Thymosin Immune Modulators Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Thymosin Immune Modulators Consumption by Regions (2016-2021)

4.2 North America Thymosin Immune Modulators Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Thymosin Immune Modulators Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Thymosin Immune Modulators Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Thymosin Immune Modulators Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Thymosin Immune Modulators Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Thymosin Immune Modulators Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Thymosin Immune Modulators Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Thymosin Immune Modulators Sales, Consumption, Export, Import (2016-2021)

4.10 South America Thymosin Immune Modulators Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Thymosin Immune Modulators Market Analysis

5.1 North America Thymosin Immune Modulators Consumption and Value Analysis

5.1.1 North America Thymosin Immune Modulators Market Under COVID-19

5.2 North America Thymosin Immune Modulators Consumption Volume by Types

5.3 North America Thymosin Immune Modulators Consumption Structure by Application

5.4 North America Thymosin Immune Modulators Consumption by Top Countries

5.4.1 United States Thymosin Immune Modulators Consumption Volume from 2016 to 2021

5.4.2 Canada Thymosin Immune Modulators Consumption Volume from 2016 to 2021

5.4.3 Mexico Thymosin Immune Modulators Consumption Volume from 2016 to 2021

Chapter 6 East Asia Thymosin Immune Modulators Market Analysis

6.1 East Asia Thymosin Immune Modulators Consumption and Value Analysis

6.1.1 East Asia Thymosin Immune Modulators Market Under COVID-19

6.2 East Asia Thymosin Immune Modulators Consumption Volume by Types

6.3 East Asia Thymosin Immune Modulators Consumption Structure by Application

6.4 East Asia Thymosin Immune Modulators Consumption by Top Countries

6.4.1 China Thymosin Immune Modulators Consumption Volume from 2016 to 2021

6.4.2 Japan Thymosin Immune Modulators Consumption Volume from 2016 to 2021

6.4.3 South Korea Thymosin Immune Modulators Consumption Volume from 2016 to 2021

Chapter 7 Europe Thymosin Immune Modulators Market Analysis

7.1 Europe Thymosin Immune Modulators Consumption and Value Analysis

7.1.1 Europe Thymosin Immune Modulators Market Under COVID-19

7.2 Europe Thymosin Immune Modulators Consumption Volume by Types

7.3 Europe Thymosin Immune Modulators Consumption Structure by Application

7.4 Europe Thymosin Immune Modulators Consumption by Top Countries

7.4.1 Germany Thymosin Immune Modulators Consumption Volume from 2016 to 2021

7.4.2 UK Thymosin Immune Modulators Consumption Volume from 2016 to 2021

7.4.3 France Thymosin Immune Modulators Consumption Volume from 2016 to 2021

7.4.4 Italy Thymosin Immune Modulators Consumption Volume from 2016 to 2021

7.4.5 Russia Thymosin Immune Modulators Consumption Volume from 2016 to 2021

7.4.6 Spain Thymosin Immune Modulators Consumption Volume from 2016 to 2021

7.4.7 Netherlands Thymosin Immune Modulators Consumption Volume from 2016 to 2021

7.4.8 Switzerland Thymosin Immune Modulators Consumption Volume from 2016 to 2021

7.4.9 Poland Thymosin Immune Modulators Consumption Volume from 2016 to 2021

Chapter 8 South Asia Thymosin Immune Modulators Market Analysis

8.1 South Asia Thymosin Immune Modulators Consumption and Value Analysis

8.1.1 South Asia Thymosin Immune Modulators Market Under COVID-19

8.2 South Asia Thymosin Immune Modulators Consumption Volume by Types

8.3 South Asia Thymosin Immune Modulators Consumption Structure by Application

8.4 South Asia Thymosin Immune Modulators Consumption by Top Countries

8.4.1 India Thymosin Immune Modulators Consumption Volume from 2016 to 2021

8.4.2 Pakistan Thymosin Immune Modulators Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Thymosin Immune Modulators Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Thymosin Immune Modulators Market Analysis

9.1 Southeast Asia Thymosin Immune Modulators Consumption and Value Analysis

9.1.1 Southeast Asia Thymosin Immune Modulators Market Under COVID-19

9.2 Southeast Asia Thymosin Immune Modulators Consumption Volume by Types

9.3 Southeast Asia Thymosin Immune Modulators Consumption Structure by Application

9.4 Southeast Asia Thymosin Immune Modulators Consumption by Top Countries

9.4.1 Indonesia Thymosin Immune Modulators Consumption Volume from 2016 to 2021

9.4.2 Thailand Thymosin Immune Modulators Consumption Volume from 2016 to 2021

9.4.3 Singapore Thymosin Immune Modulators Consumption Volume from 2016 to 2021

9.4.4 Malaysia Thymosin Immune Modulators Consumption Volume from 2016 to 2021

9.4.5 Philippines Thymosin Immune Modulators Consumption Volume from 2016 to 2021

9.4.6 Vietnam Thymosin Immune Modulators Consumption Volume from 2016 to 2021

9.4.7 Myanmar Thymosin Immune Modulators Consumption Volume from 2016 to 2021

Chapter 10 Middle East Thymosin Immune Modulators Market Analysis

10.1 Middle East Thymosin Immune Modulators Consumption and Value Analysis

10.1.1 Middle East Thymosin Immune Modulators Market Under COVID-19

10.2 Middle East Thymosin Immune Modulators Consumption Volume by Types

10.3 Middle East Thymosin Immune Modulators Consumption Structure by Application

10.4 Middle East Thymosin Immune Modulators Consumption by Top Countries

10.4.1 Turkey Thymosin Immune Modulators Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Thymosin Immune Modulators Consumption Volume from 2016 to 2021

10.4.3 Iran Thymosin Immune Modulators Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Thymosin Immune Modulators Consumption Volume from 2016 to 2021

10.4.5 Israel Thymosin Immune Modulators Consumption Volume from 2016 to 2021

10.4.6 Iraq Thymosin Immune Modulators Consumption Volume from 2016 to 2021

10.4.7 Qatar Thymosin Immune Modulators Consumption Volume from 2016 to 2021

10.4.8 Kuwait Thymosin Immune Modulators Consumption Volume from 2016 to 2021

10.4.9 Oman Thymosin Immune Modulators Consumption Volume from 2016 to 2021

Chapter 11 Africa Thymosin Immune Modulators Market Analysis

11.1 Africa Thymosin Immune Modulators Consumption and Value Analysis

11.1.1 Africa Thymosin Immune Modulators Market Under COVID-19

11.2 Africa Thymosin Immune Modulators Consumption Volume by Types

11.3 Africa Thymosin Immune Modulators Consumption Structure by Application

11.4 Africa Thymosin Immune Modulators Consumption by Top Countries

11.4.1 Nigeria Thymosin Immune Modulators Consumption Volume from 2016 to 2021

11.4.2 South Africa Thymosin Immune Modulators Consumption Volume from 2016 to 2021

11.4.3 Egypt Thymosin Immune Modulators Consumption Volume from 2016 to 2021

11.4.4 Algeria Thymosin Immune Modulators Consumption Volume from 2016 to 2021

11.4.5 Morocco Thymosin Immune Modulators Consumption Volume from 2016 to 2021

Chapter 12 Oceania Thymosin Immune Modulators Market Analysis

12.1 Oceania Thymosin Immune Modulators Consumption and Value Analysis

12.2 Oceania Thymosin Immune Modulators Consumption Volume by Types

12.3 Oceania Thymosin Immune Modulators Consumption Structure by Application

12.4 Oceania Thymosin Immune Modulators Consumption by Top Countries

12.4.1 Australia Thymosin Immune Modulators Consumption Volume from 2016 to 2021

12.4.2 New Zealand Thymosin Immune Modulators Consumption Volume from 2016 to 2021

Chapter 13 South America Thymosin Immune Modulators Market Analysis

13.1 South America Thymosin Immune Modulators Consumption and Value Analysis

13.1.1 South America Thymosin Immune Modulators Market Under COVID-19

13.2 South America Thymosin Immune Modulators Consumption Volume by Types

13.3 South America Thymosin Immune Modulators Consumption Structure by Application

13.4 South America Thymosin Immune Modulators Consumption Volume by Major Countries

13.4.1 Brazil Thymosin Immune Modulators Consumption Volume from 2016 to 2021

13.4.2 Argentina Thymosin Immune Modulators Consumption Volume from 2016 to 2021

13.4.3 Columbia Thymosin Immune Modulators Consumption Volume from 2016 to 2021

13.4.4 Chile Thymosin Immune Modulators Consumption Volume from 2016 to 2021

13.4.5 Venezuela Thymosin Immune Modulators Consumption Volume from 2016 to 2021

13.4.6 Peru Thymosin Immune Modulators Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Thymosin Immune Modulators Consumption Volume from 2016 to 2021

13.4.8 Ecuador Thymosin Immune Modulators Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Thymosin Immune Modulators Business

14.1 Roche

14.1.1 Roche Company Profile

14.1.2 Roche Thymosin Immune Modulators Product Specification

14.1.3 Roche Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Leadiant Biosciences

14.2.1 Leadiant Biosciences Company Profile

14.2.2 Leadiant Biosciences Thymosin Immune Modulators Product Specification

14.2.3 Leadiant Biosciences Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 SciClone

14.3.1 SciClone Company Profile

14.3.2 SciClone Thymosin Immune Modulators Product Specification

14.3.3 SciClone Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Merck

14.4.1 Merck Company Profile

14.4.2 Merck Thymosin Immune Modulators Product Specification

14.4.3 Merck Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Sclavo

14.5.1 Sclavo Company Profile

14.5.2 Sclavo Thymosin Immune Modulators Product Specification

14.5.3 Sclavo Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 AdiStem

14.6.1 AdiStem Company Profile

14.6.2 AdiStem Thymosin Immune Modulators Product Specification

14.6.3 AdiStem Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Lee Pharma

14.7.1 Lee Pharma Company Profile

14.7.2 Lee Pharma Thymosin Immune Modulators Product Specification

14.7.3 Lee Pharma Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 Abbiotec

14.8.1 Abbiotec Company Profile

14.8.2 Abbiotec Thymosin Immune Modulators Product Specification

14.8.3 Abbiotec Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Shanghai Soho-Yiming Pharmaceuticals

14.9.1 Shanghai Soho-Yiming Pharmaceuticals Company Profile

14.9.2 Shanghai Soho-Yiming Pharmaceuticals Thymosin Immune Modulators Product Specification

14.9.3 Shanghai Soho-Yiming Pharmaceuticals Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 Hybio Pharmaceutical

14.10.1 Hybio Pharmaceutical Company Profile

14.10.2 Hybio Pharmaceutical Thymosin Immune Modulators Product Specification

14.10.3 Hybio Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical

14.11.1 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Company Profile

14.11.2 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymosin Immune Modulators Product Specification

14.11.3 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Jiangsu Haosen Pharmaceutical Group

14.12.1 Jiangsu Haosen Pharmaceutical Group Company Profile

14.12.2 Jiangsu Haosen Pharmaceutical Group Thymosin Immune Modulators Product Specification

14.12.3 Jiangsu Haosen Pharmaceutical Group Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.13 Beijing Northland Biotechnology

14.13.1 Beijing Northland Biotechnology Company Profile

14.13.2 Beijing Northland Biotechnology Thymosin Immune Modulators Product Specification

14.13.3 Beijing Northland Biotechnology Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.14 Changchun Jinsai Pharmaceutical

14.14.1 Changchun Jinsai Pharmaceutical Company Profile

14.14.2 Changchun Jinsai Pharmaceutical Thymosin Immune Modulators Product Specification

14.14.3 Changchun Jinsai Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.15 Harbin Pharmaceutical Group Bioengineering

14.15.1 Harbin Pharmaceutical Group Bioengineering Company Profile

14.15.2 Harbin Pharmaceutical Group Bioengineering Thymosin Immune Modulators Product Specification

14.15.3 Harbin Pharmaceutical Group Bioengineering Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.16 Chengdu Shengnuo Biopharmaceutical

14.16.1 Chengdu Shengnuo Biopharmaceutical Company Profile

14.16.2 Chengdu Shengnuo Biopharmaceutical Thymosin Immune Modulators Product Specification

14.16.3 Chengdu Shengnuo Biopharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.17 Chengdu Diao Jiuhong Pharmaceutical Factory

14.17.1 Chengdu Diao Jiuhong Pharmaceutical Factory Company Profile

14.17.2 Chengdu Diao Jiuhong Pharmaceutical Factory Thymosin Immune Modulators Product Specification

14.17.3 Chengdu Diao Jiuhong Pharmaceutical Factory Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.18 Hainan Zhonghe Pharmaceutical

14.18.1 Hainan Zhonghe Pharmaceutical Company Profile

14.18.2 Hainan Zhonghe Pharmaceutical Thymosin Immune Modulators Product Specification

14.18.3 Hainan Zhonghe Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.19 Hainan Shuangcheng Pharmaceutical

14.19.1 Hainan Shuangcheng Pharmaceutical Company Profile

14.19.2 Hainan Shuangcheng Pharmaceutical Thymosin Immune Modulators Product Specification

14.19.3 Hainan Shuangcheng Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.20 Wuxi Kaifu Pharmaceutical

14.20.1 Wuxi Kaifu Pharmaceutical Company Profile

14.20.2 Wuxi Kaifu Pharmaceutical Thymosin Immune Modulators Product Specification

14.20.3 Wuxi Kaifu Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.21 Hunan Yige Pharmaceutical

14.21.1 Hunan Yige Pharmaceutical Company Profile

14.21.2 Hunan Yige Pharmaceutical Thymosin Immune Modulators Product Specification

14.21.3 Hunan Yige Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.22 Xi `an Disai bio-pharmaceutical

14.22.1 Xi `an Disai bio-pharmaceutical Company Profile

14.22.2 Xi `an Disai bio-pharmaceutical Thymosin Immune Modulators Product Specification

14.22.3 Xi `an Disai bio-pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.23 Jilin Connell Pharmaceutical

14.23.1 Jilin Connell Pharmaceutical Company Profile

14.23.2 Jilin Connell Pharmaceutical Thymosin Immune Modulators Product Specification

14.23.3 Jilin Connell Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.24 Harbin High-Tech Group Baitian`er Pharmaceutical

14.24.1 Harbin High-Tech Group Baitian`er Pharmaceutical Company Profile

14.24.2 Harbin High-Tech Group Baitian`er Pharmaceutical Thymosin Immune Modulators Product Specification

14.24.3 Harbin High-Tech Group Baitian`er Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.25 Heilongjiang Xiren Pharmaceutical Group

14.25.1 Heilongjiang Xiren Pharmaceutical Group Company Profile

14.25.2 Heilongjiang Xiren Pharmaceutical Group Thymosin Immune Modulators Product Specification

14.25.3 Heilongjiang Xiren Pharmaceutical Group Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.26 Heilongjiang Dilong Pharmaceutical

14.26.1 Heilongjiang Dilong Pharmaceutical Company Profile

14.26.2 Heilongjiang Dilong Pharmaceutical Thymosin Immune Modulators Product Specification

14.26.3 Heilongjiang Dilong Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.27 Shanghai Baolong Pharmaceutical

14.27.1 Shanghai Baolong Pharmaceutical Company Profile

14.27.2 Shanghai Baolong Pharmaceutical Thymosin Immune Modulators Product Specification

14.27.3 Shanghai Baolong Pharmaceutical Thymosin Immune Modulators Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Thymosin Immune Modulators Market Forecast (2022-2027)

15.1 Global Thymosin Immune Modulators Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Thymosin Immune Modulators Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Thymosin Immune Modulators Value and Growth Rate Forecast (2022-2027)

15.2 Global Thymosin Immune Modulators Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Thymosin Immune Modulators Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Thymosin Immune Modulators Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Thymosin Immune Modulators Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Thymosin Immune Modulators Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Thymosin Immune Modulators Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Thymosin Immune Modulators Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Thymosin Immune Modulators Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Thymosin Immune Modulators Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Thymosin Immune Modulators Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Thymosin Immune Modulators Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Thymosin Immune Modulators Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Thymosin Immune Modulators Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Thymosin Immune Modulators Consumption Forecast by Type (2022-2027)

15.3.2 Global Thymosin Immune Modulators Revenue Forecast by Type (2022-2027)

15.3.3 Global Thymosin Immune Modulators Price Forecast by Type (2022-2027)

15.4 Global Thymosin Immune Modulators Consumption Volume Forecast by Application (2022-2027)

15.5 Thymosin Immune Modulators Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology